PharVision Advisers’s Zoom ZM Stock Holding History

PharVision Advisers’s Portfolio ZM Stock Details ZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,144	Closed	-$342K	–	1047
2025 Q3	$342K	Buy	4,144 +992	+31%	+$77.4K	0.19%	153
2025 Q2	$246K	Sell	3,152 -2,453	-44%	-$190K	0.35%	145
2025 Q1	$413K	Buy	+5,605	New	+$447K	0.57%	29

Other funds holding ZM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PharVision Advisers's ZM Position: Q4 2025 in Review

PharVision Advisers sold out of Zoom (ZM) in Q4 2025, closing a stake of 4,144 shares — an estimated $342K sold.

PharVision Advisers first reported a position in ZM in Q1 2025 and held it in 3 quarters. The position peaked at $413K in Q1 2025. 823 funds tracked by Wall St. Rank hold ZM as of Q4 2025.

PharVision Advisers reported no remaining Zoom position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 4,144 Zoom shares in Q4 2025, an estimated $342K.
PharVision Advisers first reported a position in Zoom in Q1 2025 and held it in 3 quarters.
PharVision Advisers's Zoom position peaked at $413K in Q1 2025.
823 funds tracked by Wall St. Rank held Zoom as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.